Studying the impact of altered CD8+ T cell immunity in Alzheimer's disease

研究 CD8 T 细胞免疫改变对阿尔茨海默病的影响

基本信息

  • 批准号:
    10119925
  • 负责人:
  • 金额:
    $ 41.88万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2018
  • 资助国家:
    美国
  • 起止时间:
    2018-08-15 至 2023-05-31
  • 项目状态:
    已结题

项目摘要

Project Summary. Alzheimer's disease (AD) is a chronic progressive neurodegenerative disorder that accounts for 60-70% of all cases of dementia. Genetic studies reported the possible causative role of amyloid- β (Aβ), which is derived from the amyloid precursor protein (APP), in the development of AD. The accumulation of Aβ peptides in the brain can initiate the pathophysiology of AD, leading to neurofibrillary tangles and neurodegeneration. Preclinical and postmortem studies demonstrate a significant association between inflammatory pathways and the development of AD pathology. However, previous studies have focused mostly on innate immune cells. Alterations in the immune system, including T cells, occur with aging, likely contributing to the development of infections and malignancies. In human T cells, probably the most prominent change with aging is memory CD8+ T cell expansion in peripheral blood although alterations in CD4+ T cell subsets are reported as well. We found the age-associated expansion of human effector memory (EM, CCR7-CD45RA+/-) CD8+ T cells expressing low levels of IL-7 receptor alpha (IL-7Rαlow) which have distinct characteristics including effector molecules, transcription factors, and DNA methylation profiles. Recently, we investigated the possible relationship of this age-associated expansion of IL-7Rαlow EM CD8+ T cells with the global transcriptomic profile of peripheral blood cells in humans. Crossing differentially expressed genes (DEGs) in IL-7Rαlow EM CD8+ T cells against age-associated genes from human peripheral blood revealed an age-associated gene expression signature of the IL-7Rαlow EM CD8+ T cells that corresponded to 15% of the age-associated genes (244/1,497) reported by a meta-analysis study on human peripheral whole blood from approximately 15,000 individuals. A recent study reported the expansion of CD45RA+ EM CD8+ T cells in peripheral blood and cerebrospinal fluids of patients with dementia or mild cognitive impairment (MCI) due to AD, correlating with cognition. Importantly, such cells are mostly IL-7Rα(CD127)low cells. Thus, we will investigate the possible implication of the age-associated expansion of IL-7Rαlow cells in AD based on the hypothesis that patients with AD have increased levels of IL-7Rαlow EM CD8+ T cell gene signature and an expansion of these cells in peripheral blood, correlating with measures of AD severity and brain synaptic density. The goal of the proposal is to test the hypothesis with the following aims: 1) Aim 1. Elucidate that patients with AD have increased levels of IL-7Rαlow EM CD8+ T cell gene signature in peripheral blood which correlate with disease severity and brain synaptic density; and 2) Aim 2. Elucidate that patients with AD have an altered T cell profile correlating with disease severity and brain synaptic density. Overall, our supplement proposal is unique and significant since it conducts in-depth studies on the role of CD8+ T cells, especially IL- 7Rαlow EM cells, in AD, which opens a new area of research in both healthy aging and AD.
项目摘要。阿尔茨海默病(AD)是一种慢性进行性神经退行性疾病, 占所有痴呆症病例的60-70%。遗传学研究报告了淀粉样蛋白可能的致病作用- 淀粉样前体蛋白(APP)衍生的β淀粉样蛋白(Aβ)在AD的发生发展中起重要作用。的 Aβ肽在脑内的积累可启动AD的病理生理学,导致神经系统损害, 缠结和神经变性。临床前和尸检研究表明, 炎症途径和AD病理学发展之间的联系。然而,以前的研究 主要集中在先天免疫细胞上。免疫系统的改变,包括T细胞,随着年龄的增长而发生, 很可能导致感染和恶性肿瘤的发生。在人类T细胞中, 随着年龄的增长,一个显著的变化是外周血中记忆性CD 8 + T细胞的扩增,尽管CD 4 + T细胞的变化是在外周血中记忆性CD 8 + T细胞的扩增。 也报道了T细胞亚群。我们发现人类效应记忆(EM, CCR 7-CD 45 RA +/-)表达低水平IL-7受体α(IL-7 R α低)的CD 8 + T细胞,其具有明显的 这些特征包括效应分子、转录因子和DNA甲基化谱。最近我们 研究了这种与年龄相关的IL-7 R α低EM CD 8 + T细胞扩增与 人外周血细胞的总体转录组学谱。交叉差异表达基因 在IL-7 R α低EM CD 8 + T细胞中对来自人外周血的年龄相关基因的DEG的研究显示, IL-7 R α低EM CD 8 + T细胞的年龄相关基因表达特征,对应于15%的 年龄相关基因(244/1,497),由一项对来自以下人群的人外周全血的荟萃分析研究报告: 约15,000人。最近的一项研究报道了CD 45 RA + EM CD 8 + T细胞在小鼠中的扩增。 患有痴呆或轻度认知障碍(MCI)的患者的外周血和脑脊液, AD,与认知相关。重要的是,这些细胞大多是IL-7 R α(CD 127)低水平细胞。因此,我们将 研究AD患者IL-7 R α低水平细胞年龄相关性扩增的可能意义, AD患者IL-7 R α低EM CD 8 + T细胞基因标记水平升高, 这些细胞在外周血中的扩增,与AD严重程度和脑突触的测量相关。 密度的该提案的目的是检验假设,目标如下:1)目标1。阐明了 AD患者外周血中IL-7 R α低EM CD 8 + T细胞基因签名水平升高, 与疾病严重程度和脑突触密度相关;和2)Aim 2.说明AD患者有 与疾病严重程度和脑突触密度相关的T细胞谱改变。总的来说,我们的补充 该提案是独特的和重要的,因为它对CD 8 + T细胞的作用进行了深入研究,特别是IL- AD中的7 R α低EM细胞,为健康老龄化和AD开辟了新的研究领域。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Insoo Kang其他文献

Insoo Kang的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Insoo Kang', 18)}}的其他基金

Investigating monocyte activation pathways in lupus
研究狼疮中的单核细胞激活途径
  • 批准号:
    10731104
  • 财政年份:
    2023
  • 资助金额:
    $ 41.88万
  • 项目类别:
Studying alterations of T cell immune responses in the 17q12 deletion syndrome
研究 17q12 缺失综合征中 T 细胞免疫反应的变化
  • 批准号:
    10518405
  • 财政年份:
    2021
  • 资助金额:
    $ 41.88万
  • 项目类别:
Studying alterations of T cell immune responses in the 17q12 deletion syndrome
研究 17q12 缺失综合征中 T 细胞免疫反应的变化
  • 批准号:
    10391990
  • 财政年份:
    2021
  • 资助金额:
    $ 41.88万
  • 项目类别:
Aging and IL-7 mediated CD8+ T cell survival
衰老和 IL-7 介导的 CD8 T 细胞存活
  • 批准号:
    10443824
  • 财政年份:
    2018
  • 资助金额:
    $ 41.88万
  • 项目类别:
Aging and IL-7 mediated CD8+ T cell survival
衰老和 IL-7 介导的 CD8 T 细胞存活
  • 批准号:
    10207438
  • 财政年份:
    2018
  • 资助金额:
    $ 41.88万
  • 项目类别:
Aging and IL-7 mediated CD8+ T cell survival
衰老和 IL-7 介导的 CD8 T 细胞存活
  • 批准号:
    9764233
  • 财政年份:
    2018
  • 资助金额:
    $ 41.88万
  • 项目类别:
The Impact of Aging and HIV Infection on Immunologic and Transcriptomic Signatures of Influenza Vaccine Response
衰老和 HIV 感染对流感疫苗反应的免疫学和转录组学特征的影响
  • 批准号:
    10183118
  • 财政年份:
    2017
  • 资助金额:
    $ 41.88万
  • 项目类别:
Studying the effects of vitamin D on FOXP3 and IL-17 expression in human CD4+ T c
研究维生素 D 对人 CD4 T c 中 FOXP3 和 IL-17 表达的影响
  • 批准号:
    7938575
  • 财政年份:
    2009
  • 资助金额:
    $ 41.88万
  • 项目类别:
Studying the effects of vitamin D on FOXP3 and IL-17 expression in human CD4+ T c
研究维生素 D 对人 CD4 T c 中 FOXP3 和 IL-17 表达的影响
  • 批准号:
    7706357
  • 财政年份:
    2009
  • 资助金额:
    $ 41.88万
  • 项目类别:
Lymphoid neogenesis and CD4+T cell differentiation in primary Sjogren's syndrome
原发性干燥综合征中的淋巴新生和 CD4 T 细胞分化
  • 批准号:
    7687681
  • 财政年份:
    2009
  • 资助金额:
    $ 41.88万
  • 项目类别:

相似国自然基金

靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
  • 批准号:
    JCZRQN202500010
  • 批准年份:
    2025
  • 资助金额:
    0.0 万元
  • 项目类别:
    省市级项目
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
  • 批准号:
    2025JJ70209
  • 批准年份:
    2025
  • 资助金额:
    0.0 万元
  • 项目类别:
    省市级项目
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
  • 批准号:
  • 批准年份:
    2024
  • 资助金额:
    0 万元
  • 项目类别:
    面上项目
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
  • 批准号:
    2023JJ50274
  • 批准年份:
    2023
  • 资助金额:
    0.0 万元
  • 项目类别:
    省市级项目
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
  • 批准号:
  • 批准年份:
    2022
  • 资助金额:
    33 万元
  • 项目类别:
    地区科学基金项目
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
  • 批准号:
  • 批准年份:
    2022
  • 资助金额:
    10.0 万元
  • 项目类别:
    省市级项目
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
  • 批准号:
    81973577
  • 批准年份:
    2019
  • 资助金额:
    55.0 万元
  • 项目类别:
    面上项目
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
  • 批准号:
    81602908
  • 批准年份:
    2016
  • 资助金额:
    18.0 万元
  • 项目类别:
    青年科学基金项目
高血糖激活滑膜AGE-RAGE-PKC轴致骨关节炎易感的机制研究
  • 批准号:
    81501928
  • 批准年份:
    2015
  • 资助金额:
    18.0 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

The Phenomenon of Stem Cell Aging according to Methylation Estimates of Age After Hematopoietic Stem Cell Transplantation
根据造血干细胞移植后甲基化年龄估算干细胞衰老现象
  • 批准号:
    23K07844
  • 财政年份:
    2023
  • 资助金额:
    $ 41.88万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Analysis of Age-dependent Functional Changes in Skeletal Muscle CB1 Receptors by an in Vitro Model of Aging-related Muscle Atrophy
通过衰老相关性肌肉萎缩的体外模型分析骨骼肌 CB1 受体的年龄依赖性功能变化
  • 批准号:
    22KJ2960
  • 财政年份:
    2023
  • 资助金额:
    $ 41.88万
  • 项目类别:
    Grant-in-Aid for JSPS Fellows
Joint U.S.-Japan Measures for Aging and Dementia Derived from the Prevention of Age-Related and Noise-induced Hearing Loss
美日针对预防与年龄相关和噪声引起的听力损失而导致的老龄化和痴呆症联合措施
  • 批准号:
    23KK0156
  • 财政年份:
    2023
  • 资助金额:
    $ 41.88万
  • 项目类别:
    Fund for the Promotion of Joint International Research (International Collaborative Research)
The Effects of Muscle Fatigability on Gait Instability in Aging and Age-Related Falls Risk
肌肉疲劳对衰老步态不稳定性和年龄相关跌倒风险的影响
  • 批准号:
    10677409
  • 财政年份:
    2023
  • 资助金额:
    $ 41.88万
  • 项目类别:
Characterizing gut physiology by age, frailty, and sex: assessing the role of the aging gut in "inflamm-aging"
按年龄、虚弱和性别表征肠道生理学特征:评估衰老肠道在“炎症衰老”中的作用
  • 批准号:
    497927
  • 财政年份:
    2023
  • 资助金额:
    $ 41.88万
  • 项目类别:
Role of AGE/RAGEsignaling as a driver of pathological aging in the brain
AGE/RAGE信号传导作为大脑病理性衰老驱动因素的作用
  • 批准号:
    10836835
  • 财政年份:
    2023
  • 资助金额:
    $ 41.88万
  • 项目类别:
Deciphering the role of osteopontin in the aging eye and age-related macular degeneration
破译骨桥蛋白在眼睛老化和年龄相关性黄斑变性中的作用
  • 批准号:
    10679287
  • 财政年份:
    2023
  • 资助金额:
    $ 41.88万
  • 项目类别:
Targeting Age-Activated Proinflammatory Chemokine Signaling by CCL2/11 to Enhance Skeletal Muscle Regeneration in Aging
通过 CCL2/11 靶向年龄激活的促炎趋化因子信号传导以增强衰老过程中的骨骼肌再生
  • 批准号:
    478877
  • 财政年份:
    2023
  • 资助金额:
    $ 41.88万
  • 项目类别:
    Operating Grants
Elucidation of the protein kinase NLK-mediated aging mechanisms and treatment of age-related diseases
阐明蛋白激酶NLK介导的衰老机制及年龄相关疾病的治疗
  • 批准号:
    23K06378
  • 财政年份:
    2023
  • 资助金额:
    $ 41.88万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Underlying mechanisms of age-related changes in ingestive behaviors: From the perspective of the aging brain and deterioration of the gustatory system.
与年龄相关的摄入行为变化的潜在机制:从大脑老化和味觉系统退化的角度来看。
  • 批准号:
    23K10845
  • 财政年份:
    2023
  • 资助金额:
    $ 41.88万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了